-
Low-dose Naltrexone: What's New
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing consider...
-
Clinical Applications for Low-Dose Naltrexone
Run time: 1 hour
Download handout: https://bit.ly/38E2nndNat Jones, a licensed pharmacist in Texas, graduated from the Virginia Commonwealth University, Medical College of Virginia’s School of Pharmacy in 1979. In 2014, after 20 years of owning a compounding pharmacy in Virginia, he joined Pro...
-
Application of LDN in Autoimmune GI Disorders
Run time: 1 hour 5 minutes
Download handout: https://bit.ly/3hr7hdGIn this lecture Dr. Radha Tamerisa discusses the potential applications of low dose naltrexone and describes basic gut anatomy, function and disruption. She also explains various GI conditions such as ulcerative colitits, Crohn’...
-
Utilization of LDN in the Pediatric Population
Utilization of LDN in the Pediatric Population
31 min
Handout: https://bit.ly/4eG3KA7During this session, Trcia Heitman, PharmD, will discuss why low dose naltrexone (LDN) is a good therapeutic option in pediatric autoimmune disease, the literature available supporting the use of LDN in childr...
-
COVID-19 and Post-COVID-19 Syndrome
57 min
Handout: https://bit.ly/49AiLCEDuring this session, Pamela W. Smith, MD, MPH, MS will discuss precision medicine adjunct therapies for COVID-19 and explore precision medicine adjuct treatments for Post COVID-19 Syndrome and Post COVID-19 Vaccine Syndrome.
-
Autoimmune Diseases and the Use of LDN (cont.)
45 Minutes
Handout: https://bit.ly/3AecPlyDuring this session, Pamela W. Smith, MD, MPH, MS will discuss autoimmune diseases and the use of LDN.
-
Autoimmune Diseases and the Use of LDN
1 Hour 14 Minutes
Handout: https://bit.ly/3AecPlyDuring this session, Pamela W. Smith, MD, MPH, MS will discuss autoimmune diseases and the use of LDN.
-
Introduction to Low Dose Naltrexone
1 Hour 8 Minutes
Handout: https://bit.ly/3NCwi2uDuring this session, Sebastian Denison, RPh, FAARM (candidate) and Tricia Heitman, PharmD will discuss the basics of Low-Dose Naltrexone.
-
Hashimoto's Thyroiditis and The Use of LDN
Run time: 1 hour 5 minutes
Download handout: https://bit.ly/3gVr9psIn this presentation Dr. Zielsdorf, MD, MS explains the signs, symptoms, and treatment options for Hashimoto’s. She also describes the role of LDN as a vital adjunct to AITD and then reviews the current literature supporting the...
-
Improving Patients’ Lives with Low-Dose Naltrexone
Download Handout:
Run Time: 57 minutesApproximately 50 million Americans, 20 percent of the population, suffer from autoimmune diseases and more than 100 autoimmune disorders have been identified to date. The good news? Low-dose naltrexone (LDN) has been studied recently regarding its applicat...
-
How Pharmacists Can Partner with Practitioners to Expand LDN Awareness
During this presentation, Dr. Sarah Zielsdorf, MD, MS will share how pharmacists can partner with their practitioners to expand awareness of LDN.
-
Back to Basics: Understanding the Immune System and Autoimmune Disorders
Run time: 1 hour 7 minutes
Download handout: https://bit.ly/3V307xNDuring this presentation, PCCA’s Clinical Compounding Pharmacist, Sebastian Denison will share basics about understanding the immune system and autoimmune disorders. After watching this presentation, the viewer should be able to...
-
LDN Compounding Opportunities: Post-COVID, Autoimmune, Dermatology, and More
Run time: 2 hour 15 minutes
Download handout: https://bit.ly/3P7ZGhYThis compilation of four presentations from PCCA’s Clinical Compounding Pharmacists will feature presentations covering formulas to help with symptoms related to Parkinson’s Disease, Multiple Sclerosis, ALS, Hashimoto’s and Lup...
-
LDN and Its Use in Memory Loss and Cancer
Run time: 1 hour 8 minutes
Download handout: https://bit.ly/3P7Zz62During this presentation, Dr. Pam Smith will share LDN uses in treating memory loss and cancer. After watching this presentation, the viewer should be able to:
- Describe various causes of inflammation and the role inflammation ... -
What Works for Me: How I Market LDN to Practitioners
Run time: 1 hour 6 minutes
Download handout: https://bit.ly/3Ij3oBPDuring this presentation, PCCA members Katie Lewis, Stacy Hightower, and Michael Stevelman will share what works for them when marketing LDN to practitioners.
-
Low-Dose Naltrexone: What's New
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing consider...
-
Compounding for Chronic Disease and Cellular Health
Download Handout: https://bit.ly/478vIRZ
Run Time: 34 minutesPCCA Clinical Compounding Pharmacist Nat Jones reveals nutritional supplements and compounds for the health conditions such as insulin resistance, oxidative stress, and increasing mitochondrial energy production.
-
Low-Dose Naltrexone (LDN): Updates That Might Be Important
40min
Handout: https://bit.ly/3W3OeYr
In this presentation Sebastian Denison, RPh, FAARM (cand.), talks about updates that might be important in regards to low-dose naltrexone.
-
Marketing LDN Formulas
38 Min
Handout: https://bit.ly/3PHd10V
In this presentation Sebastian Denison, RPh, FAARM (cand.), talks about how to market LDN formulas.